Potential interaction of troglitazone and cyclosporine

Transplantation

Volumn 65, Issue 10, 1998, Pages 1399-1400

  Kaplan, Bruce ^a   Friedman, Gary ^a   Jacobs, Martin ^a   Viscuso, Ronald ^a   Lyman, Neil ^a   DeFranco, Penny ^a   Bonomini, Luigi ^a   Mulgaonkar, Shamkant P ^a  

^a SAINT BARNABAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TROGLITAZONE;

ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; FOOD AND DRUG ADMINISTRATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

ACUTE DISEASE; CHROMANS; CYCLOSPORINE; DRUG INTERACTIONS; FEMALE; GRAFT REJECTION; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; OSMOLAR CONCENTRATION; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0032571982     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805270-00021     Document Type: Article

References (8)

1. Keown PA, Stiller CR, Laupacis AL, et al: The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplant Proc 1982; 14; 659.
2. Yee GC, Kennedy MS: Cyclosporine in applied pharmacokinetics. Evans WE, Schentay JJ, Jusko WJ, eds. Applied therapeutics. Spokane, WA: Applied Therapeutics, Inc., 1986.
3. Inoue I, Takahashi K, Katayama S, et al: Effect of troglitazone (CS-045) and betatibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose fed rats. Metabolism 1995; 44(12): 1626.
4. Rezulin Troglitazone Tablets (package insert). Parke-Davis Pharmaceuticals, Limited. October, 1997.
5. Gomez DY, Wacher VJ, Tomlanovich SJ, Hebert MF, Benet LZ: The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. Clin Pharmacol Ther 1995; 58: 15.
6. Wu CY, Benet LZ, Hebert MF, et al: Differentiation of absorption of first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin Pharmacol Ther 1995; 58: 492.
7. Hebert MF, Robert JP, Prueksaritanout T, Benet LZ: Bioavailability of cyclosporine with concomitant rifampin: administration is markedly less than predicted by hepatic enzyme inhibition. Clin Pharmacol Ther 1992; 52: 453.
8. Mueller EA, Kovarik JM, van Bree JB, Lison AE, Kutz K: Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients: a concentration-controlled comparison with the commercial formulation. Transplantation 1994; 57: 1178.